Charlesbank Capital Partners has invested in HBox to enhance its virtual care capabilities, supporting the transformation of care for high-risk chronic patients in independent specialty clinics.

Information on the Target

HBox is a prominent virtual care platform dedicated to supporting independent specialty clinics. The platform offers an integrated, AI-driven solution that merges connected medical devices, patient engagement tools, and comprehensive care services to effectively establish a virtual clinic within existing clinic environments. HBox serves primarily cardiology and various specialty teams, facilitating the delivery of care beyond traditional in-person settings. This innovative approach allows healthcare providers to manage larger populations suffering from chronic conditions while ensuring that they receive high-quality, personalized care.

With its technology, HBox enables healthcare practitioners to maintain close contact with patients, enhancing the overall care experience and ensuring that chronic health issues are effectively monitored and addressed. The platform's ability to extend the reach of healthcare services not only improves patient outcomes but also supports specialty clinics in managing their workload efficiently.

Industry Overview in the Target’s Specific Country

The virtual care industry in the United States has seen significant transformation in recent years, driven by advancements in technology and the increasing demand for accessible healthcare solutions. As patients seek more convenient ways to receive care, the market for

View Source

Similar Deals

S2G Investments Faeth Therapeutics

2025

Other VC Bio Therapeutic Drugs United States of America
Marlin Equity Partners Intelligent Locations

2025

Other VC Hospitals, Clinics & Primary Care Services United States of America
Resonex Ventures OneVue

2025

Other VC Telemedicine Services United States of America
Rittenhouse Ventures S2N Health, Inc.

2025

Other VC Medical Software & Technology Services United States of America
Samsung C2N Diagnostics

2025

Other VC Bio Diagnostics & Testing United States of America
삼성물산 C2N Diagnostics

2025

Other VC Bio Diagnostics & Testing United States of America

Charlesbank

invested in

HBox

in 2025

in a Other VC deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert